90 related articles for article (PubMed ID: 61996)
1. B lymphocyte alloantigen specificities present on cultured lymphoblastoid cell lines.
Honig R; Billing R; Matsuyama M; Terasaki PJ
J Immunol; 1976 Oct; 117(4):1300-2. PubMed ID: 61996
[TBL] [Abstract][Full Text] [Related]
2. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
Yannelli JR; Moore LC; Engelhard VH
J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
[TBL] [Abstract][Full Text] [Related]
3. Simplification of B-cell antisera of the Merrit system with platelets and lymphoblastoid cell lines.
Naeim F; Gregg B; Gatti RA; Leibold W; Walford RL
Transplant Proc; 1977 Mar; 9(1):439-44. PubMed ID: 68582
[TBL] [Abstract][Full Text] [Related]
4. Distribution of HLA-A, B, C and the Merrit B-cell alloantigen specificities in chronic lymphatic leukemia.
Gossett T; Walford R; Gatti RM
Prog Clin Biol Res; 1977; 16():55-63. PubMed ID: 71744
[TBL] [Abstract][Full Text] [Related]
5. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
6. Recognition by human and rabbit sera of common antigens to leukemia blast cells, peripheral blood B-lymphocytes, and monocytes.
Zighelboim J; Bick A; Durantez A
Cancer Res; 1977 Oct; 37(10):3656-62. PubMed ID: 71197
[TBL] [Abstract][Full Text] [Related]
7. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
[TBL] [Abstract][Full Text] [Related]
8. Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.
Winchester RJ; Wernet P; Kunkel HG; Dupont B; Jersild C; Fu SM
J Exp Med; 1975 Apr; 141(4):924-9. PubMed ID: 47890
[TBL] [Abstract][Full Text] [Related]
9. Specificities in natural cell-mediated cytotoxicity against lymphoblastoid cell lines. I. Selective inhibition by cross-competition.
Koide Y; Takasugi M
Eur J Immunol; 1978 Nov; 8(11):818-22. PubMed ID: 82513
[TBL] [Abstract][Full Text] [Related]
10. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
11. B lymphoblastoid cell lines with rearranged T cell receptor beta-chain genes retain conventional B cell surface antigen and Ig expression.
Robinson MA; Kindt TJ
J Immunol; 1988 Feb; 140(4):1327-34. PubMed ID: 2830338
[TBL] [Abstract][Full Text] [Related]
12. Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. II. Detection by human anti-B-cell alloantisera.
Billing R; Ting A; Terasaki PI
J Natl Cancer Inst; 1977 Feb; 58(2):199-203. PubMed ID: 64614
[TBL] [Abstract][Full Text] [Related]
13. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
[TBL] [Abstract][Full Text] [Related]
14. Reaction of various human normal and leukemic cells and cells of different cell lines with rabbit antisera prepared against membrane fraction of B and T cell lines.
Koubek K
Neoplasma; 1983; 30(2):187-95. PubMed ID: 6188960
[TBL] [Abstract][Full Text] [Related]
15. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
16. Human B cell alloantigens: expression of MB and MT determinants.
Markert ML; Cresswell P
J Immunol; 1982 May; 128(5):2004-8. PubMed ID: 6174619
[TBL] [Abstract][Full Text] [Related]
17. Detection of HLA (Ia) and non-HLA specificities by "B-cell" antisera.
Thompson JS; Severson CD; Greazel NA; Ferrone S
Transplant Proc; 1977 Mar; 9(1):597-600. PubMed ID: 68591
[No Abstract] [Full Text] [Related]
18. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
19. Antigenic specificities detected on papainized human granulocytes by microgranulocytotoxicity.
Drew SI; Bergh O; McClelland J; Mickey R; Terasaki PI
Transplant Proc; 1977 Mar; 9(1):639-45. PubMed ID: 68596
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
